What is Staar Surgical Co. Annual Revenue?

Staar Surgical Co. Annual Revenue fell 2.64%, in the last year to $313.9 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

What is Staar Surgical Co. Annual Net Profit?

Staar Surgical Co. Annual Net Profit fell 194.66% in the last year to $20.21 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

What is Staar Surgical Co. Price to Earning Ratio?

Staar Surgical Co. Price to Earning Ratio is -40.42, which is negative.

What is Staar Surgical Co. Stock Price?

Staar Surgical Co. Stock Price fell 64.3% and underperformed its sector by 69.56% in the past year.

What is Staar Surgical Co. Quarterly Revenue?

Staar Surgical Co. Quarterly Revenue fell 35.82% YoY to $48.95 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

What is Staar Surgical Co. Quarterly Net profit?

Staar Surgical Co. Quarterly Net profit fell 541.31% YoY to $34.23 M. Its sector's average net profit growth YoY for the quarter was 32.89%.

What is Staar Surgical Co. Debt to Equity Ratio?

Staar Surgical Co. Debt to Equity Ratio of 0.1 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Staar Surgical Co. Return on Equity(ROE)?

Staar Surgical Co. Return on Equity(ROE) for the last financial year was -5.16%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Staar Surgical Co. Mutual Fund Holding?

Staar Surgical Co. Mutual Fund Holding decreased by 1.78% in the last quarter to 51.7.

What is Staar Surgical Co. Promoter Share Holding?

Staar Surgical Co. Promoter Share Holding decreased by 0.18% in the most recent quarter to 0.45%.

What is Staar Surgical Co. Institutional Holding?

Staar Surgical Co. Institutional Holding increased by 0.03% in the last quarter to 98.54.

How is the Staar Surgical Co. today?

The Staar Surgical Co. today is trading in the down by -1.95% at 16.56.

How has Staar Surgical Co. performed historically?

The Staar Surgical Co. is currently trading down -1.95% on an intraday basis in the past week the index fell -1.37%. The index has been down -25.71% in the past quarter and fell -64.30% in the past year. You can view this in the overview section.

Staar Surgical Co. XNAS: STAA

Staar Surgical Co. Live Share Price Today, Share Analysis and Chart

Name: Staar Surgical Co.: Is Infosys Ltd. worth buying?
Item: Staar Surgical Co.
Rating: 0.93752775
Author: Trendlyne DVM scores

Weak Stock

Download real time

16.56 -0.33 (-1.95%)

66.79% Fall from 52W High

371.4K XNAS Volume

XNAS 21 Apr, 2025 3:57 PM (EDT)

Staar Surgical Co. Key Metrics

My Metrics

Select

Market Capitalization Below industry Median Unavailable in chosen country	816.8
PE TTM Negative PE TTM Unavailable in chosen country	-40.4
PEG TTM Below industry Median Unavailable in chosen country	0.2
Price to Book Below industry Median Unavailable in chosen country	2.1
Institutional holding current Qtr % High in industry Unavailable in chosen country	98.5
Revenue Growth Qtr YoY % Negative Revenue Growth Qtr YoY % Unavailable in chosen country	-35.8
Operating Revenue growth TTM % Negative Operating Revenue growth TTM % Unavailable in chosen country	-2.6
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-541.3
Net Profit TTM Growth % Negative Net Profit TTM Growth % Unavailable in chosen country	-194.7
Operating Profit Margin Qtr % Negative Operating Profit Margin Qtr % Unavailable in chosen country	-57
Operating Profit Margin TTM % Negative Operating Profit Margin TTM % Unavailable in chosen country	-4
Piotroski Score Low in industry Unavailable in chosen country	1
Rel Perf vs Sector quarter% Unavailable in chosen country	-16.7
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-5.2
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-4

All financials are in USD Million and price data in USD

Low Financial Strength

11.1 / 100

Expensive Valuation

19.5 / 100

Technically Bearish

33.3 / 100

Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 13%

9 analysts

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Staar Surgical Co. Stock Price Analysis

Day Price Range -2.0% 1 Day return Unavailable in chosen country	16.6 (LTP) 1616.6 LowHigh
Week Price Range -1.4% 1 Week return Unavailable in chosen country	16.6 (LTP) 1617.5 LowHigh
Month Price Range -7.6% 1 Month return Unavailable in chosen country	16.6 (LTP) 14.718.2 LowHigh
52 Week Price Range -64.3% 1 Year return Unavailable in chosen country	16.6 (LTP) 13.549.9 LowHigh

View full Share Price History

Staar Surgical Co. Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Miss

Staar Surgical Co.'s Revenue was lower than average estimate 2 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

-0.4

Avg. Estimate

-1.3

Low Estimate

-1.7

High Estimate

-0.9

Current EPS

Avg. Estimate

Consensus Recommendation

13 ANALYST Recommendations

HOLD

The consensus recommendation from 13 analysts for Staar Surgical Co. is HOLD

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Staar Surgical Co. Stock Analysis

Staar Surgical Co. stock analysis with key metrics, changes, and trends.

Staar Surgical Co. Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$313.9 M	2.64%	negative	Annual Revenue fell 2.64%, in the last year to $313.9 M. Its sector's average revenue growth for the last fiscal year was 8.57%.
Annual Net Profit	$20.21 M	194.66%	negative	Annual Net Profit fell 194.66% in the last year to $20.21 M. Its sector's average net profit growth for the last fiscal year was 4.36%.
Price to Earning Ratio	-40.42	-	negative	Price to Earning Ratio is -40.42, which is negative.
Stock Price	$16.56	-64.3%	negative	Stock Price fell 64.3% and underperformed its sector by 69.56% in the past year.
Quarterly Revenue	$48.95 M	35.82%	negative	Quarterly Revenue fell 35.82% YoY to $48.95 M. Its sector's average revenue growth YoY for the quarter was 8.5%.
Quarterly Net profit	$34.23 M	541.31%	negative	Quarterly Net profit fell 541.31% YoY to $34.23 M. Its sector's average net profit growth YoY for the quarter was 32.89%.
Debt to Equity Ratio	0.1	-	positive	Debt to Equity Ratio of 0.1 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	-5.16 %	-5.16%	negative	Return on Equity(ROE) for the last financial year was -5.16%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	51.70 %	-1.78%	negative	Mutual Fund Holding decreased by 1.78% in the last quarter to 51.7.
Promoter Share Holding	0.45 %	-0.18%	negative	Promoter Share Holding decreased by 0.18% in the most recent quarter to 0.45%.
Institutional Holding	98.54 %	0.03%	positive	Institutional Holding increased by 0.03% in the last quarter to 98.54.

VIEW LESS

Loading data..

Staar Surgical Co. - Company Profile

What does Staar Surgical Co. do?

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

Gross Remuneration

2025

Gross Remuneration

Year

Staar Surgical Co. Live Share Price Today, Share Analysis and Chart

66.79% Fall from 52W High

Staar Surgical Co. Key Metrics

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Staar Surgical Co. Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Staar Surgical Co. Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Staar Surgical Co.'s Revenue was lower than average estimate 2 times in past 3 years

EPS forecast

Consensus Recommendation

The consensus recommendation from 13 analysts for Staar Surgical Co. is HOLD

Staar Surgical Co. Stock Analysis

Staar Surgical Co. stock analysis with key metrics, changes, and trends.

Annual Revenue fell 2.64%, in the last year to $313.9 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit fell 194.66% in the last year to $20.21 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio is -40.42, which is negative.

Stock Price fell 64.3% and underperformed its sector by 69.56% in the past year.

Quarterly Revenue fell 35.82% YoY to $48.95 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit fell 541.31% YoY to $34.23 M. Its sector's average net profit growth YoY for the quarter was 32.89%.

Debt to Equity Ratio of 0.1 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was -5.16%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding decreased by 1.78% in the last quarter to 51.7.

Promoter Share Holding decreased by 0.18% in the most recent quarter to 0.45%.

Institutional Holding increased by 0.03% in the last quarter to 98.54.

Staar Surgical Co. - Company Profile

What does Staar Surgical Co. do?

Staar Surgical Co. Management structure

Mr. Stephen C. Farrell

Director and Chief Executive Officer

Mr. Thomas G. Frinzi

President, Chief Executive Officer and Chairman of the Board

Ms. Deborah Andrews

Interim Chief Financial Officer

Mr. Patrick F. Williams

Vice President, Chief Financial Officer and Principal Accounting Officer

Mr. Keith Holliday

Chief Technology Officer and Head of the Research and Development

Dr. Magda Michna

Chief Development Officer

Staar Surgical Co. Board of directors

Mr. Stephen C. Farrell

Director and Chief Executive Officer

Mr. Thomas G. Frinzi

President, Chief Executive Officer and Chairman of

Dr. Elizabeth Yeu, M.D.

Chairman of the Board

Staar Surgical Co. FAQ

How is Staar Surgical Co. today?

Staar Surgical Co. today is trading in the red, and is down by -1.95% at 16.56.

How has Staar Surgical Co. performed historically?

Staar Surgical Co. is currently trading down -1.95% on an intraday basis. In the past week the stock fell -1.37%. stock has been down -25.71% in the past quarter and fell -64.30% in the past year. You can view this in the overview section.